Drug Profile
NAP 5
Alternative Names: Nematode anticoagulation peptide 5; rNAP-5Latest Information Update: 06 Sep 2002
Price :
$50
*
At a glance
- Originator Dendreon San Diego LLC
- Developer Dendreon San Diego LLC; Schering-Plough
- Class Antithrombotics
- Mechanism of Action Factor Xa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Coronary thrombosis; Thrombosis
Most Recent Events
- 06 Sep 2002 Discontinued - Preclinical for Coronary thrombosis in USA (SC)
- 06 Sep 2002 Discontinued - Preclinical for Thrombosis in USA (IV)
- 06 Sep 2002 Discontinued - Preclinical for Thrombosis in USA (SC)